サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1705645

静脈注射液市場：溶液別、バッグタイプ別、用途別、エンドユーザー別、地域別市場規模、シェア、展望、機会分析、2025年～2032年

Intravenous Solutions Market, by Solution, by Bag Type, by Application, by End User, and by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日
ページ情報
英文 215 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
静脈注射液市場：溶液別、バッグタイプ別、用途別、エンドユーザー別、地域別市場規模、シェア、展望、機会分析、2025年～2032年
出版日: 2025年03月03日
発行: Coherent Market Insights
ページ情報: 英文 215 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

静脈注射液の世界市場は、2025年には110億5,000万米ドルと推定され、2032年には169億5,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は6.3%で成長すると予測されています。

レポート範囲 レポート詳細
基準年 2024年 2025年の市場規模 110億5,000万米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間：2025年～2032年 CAGR： 6.30% 2032年の価値予測 169億5,000万米ドル
図.静脈注射液市場シェア（%）、2025年地域別
Intravenous Solutions Market-IMG1

静脈内ソリューションは、静脈循環に直接投与される体液です。これらの輸液は無菌の非パイロジェン性溶液であり、静脈内投与用の単回投与容器に入れられ、水分補給やカロリー補給に使用されます。塩化ナトリウム、乳酸リンゲル、水中ブドウ糖など、市場で入手可能な静脈注射液にはさまざまな種類があります。点滴療法は、栄養不足や脱水に悩む患者に最適です。脱水は、以下のようなさまざまな影響を引き起こす可能性があります。

  • 体内の重要なミネラル（電解質）のバランス。
  • 認知（精神）能力
  • エネルギーレベル
  • 胃腸機能（食べ物を消化し、おしっこやうんちを作る能力）
  • 頭痛の頻度と強さ
  • 身体能力
  • 皮膚の健康状態

市場力学

下痢症の有病率の増加が、予測期間中の世界の静脈注射液市場の成長を押し上げると予想されます。例えば、2022年7月、世界中の子どもたちに人道的・開発的援助を提供する国連の機関であるUNICEF（国連国際児童緊急基金）は、下痢による2020年の世界の5歳未満の子どもの全死亡の9％を占め、一方、下痢により毎日1,300人以上の幼児が死亡し、世界全体で年間約48万4,000人の子どもが死亡しているという報告書を発表しました。

さらに、2018年9月のLancet Infectious Diseasesに掲載された論文によると、下痢症は2016年の障害調整生存年（DALYs）の第3位の原因であり、世界全体で7,440万DALYsを占めています。同出典によると、下痢症は死亡原因の第8位であり、2016年の死亡者数は世界全体で165万5,944人でした。

本調査の主な特徴

  • 当レポートでは、世界の静脈注射液市場について、2024年を基準年とした予測期間：2025年～2032年の市場規模を詳細に分析しています。
  • さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案マトリクスを説明します。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競合戦略などに関する重要な考察も提供しています。
  • 企業概要、財務実績、製品ポートフォリオ、地理的プレゼンス、流通戦略、主な発展、戦略などのパラメータに基づいて、世界の点滴ソリューション市場の主要企業プロファイルを掲載しています。
  • 本レポートの洞察により、企業のマーケティング担当者や経営陣は、将来の製品発売、政府の取り組み、技術向上、市場拡大、マーケティング戦術に関して、情報に基づいた意思決定を行うことができます。
  • この調査レポートは、投資家、製品メーカー、流通業者、利害関係者、調査会社、コンサルティング会社、新規参入企業、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。
  • 利害関係者は、世界の静脈注射液市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 市場動向
  • 主な発展
  • 疫学
  • ポーターのファイブフォース分析

第4章 世界の静脈注射液市場-コロナウイルス（COVID-19）パンデミックの影響

  • 全体的な影響
  • COVID-19による市場への影響

第5章 世界の静脈注射液市場、溶液別、2020年～2032年

  • 生理食塩水
  • 生理食塩水（0.9% NaCl）
  • 高張食塩水
  • デキストラン
  • 乳酸リンゲル液
  • アミノ酸
  • ビタミンとミネラル
  • ヘパリンと微量元素
  • 混合ソリューション

第6章 世界の静脈注射液市場、バッグタイプ別、2020年～2032年

  • 大容量バッグ（250ml以上）
  • 小容量バッグ（250ml未満）

第7章 世界の静脈注射液市場、用途別、2020年～2032年

  • 基本的なIV溶液
  • 栄養点滴液
  • 輸血液
  • 薬剤点滴液
  • 灌漑IV溶液

第8章 世界の静脈注射液市場、エンドユーザー別、2020年～2032年

  • 病院
  • クリニック
  • 外来手術センター
  • ホームケア設定

第9章 世界の静脈注射液市場、地域別、2020年～2032年

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第10章 競合情勢

  • ヒートマップ分析
  • 企業プロファイル
    • Baxter International Inc.
    • ICU Medical, Inc.
    • B. Braun Melsungen Ag
    • Grifols, SA
    • Fresenius Kabi USA, LLC
    • Vifor Pharma Management Ltd.
    • JW Life Science
    • Amanta Healthcare
    • Axa Parenterals Ltd
    • Salius Pharma Private Limited.
    • Pfizer, Inc.
    • Otsuka Pharmaceutical Co., Ltd
    • Ajinomoto Co., Inc.
    • Braun Melsungen AG
    • Soxa Formulations &Research Pvt. Ltd
    • Sichuan Kelun Pharmaceutical Co Ltd

第11章 アナリストの推奨事項

  • 運命の輪
  • アナリストの見解
  • 一貫性のある機会マップ

第12章 セクション

  • 参考文献
  • 調査手法
目次
Product Code: CMI1134

Global Intravenous Solutions Market is estimated to be valued at USD 11.05 Bn in 2025 and is expected to reach USD 16.95 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.05 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.30% 2032 Value Projection: USD 16.95 Bn
Figure. Intravenous Solutions Market Share (%), By Region 2025
Intravenous Solutions Market - IMG1

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. Dehydration can contribute to various affects such as

  • Balance of important minerals (electrolytes) in the body.
  • Cognitive (mental) performance.
  • Energy level.
  • Gastrointestinal function (your ability to digest food and create pee and poop).
  • Headache frequency and intensity.
  • Physical performance.
  • Skin health.

Market Dynamics

Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, in July 2022, UNICEF (United Nations International Children's Emergency Fund), an agency of the United Nations responsible for providing humanitarian and developmental aid to children worldwide, published a report which accounted for 9 per cent of all deaths among children under age 5 worldwide in 2020 due to Diarrhoea, whereas over 1,300 young children dying each day, or about 484,000 children a year globally due to diarrhoea.

Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016 globally.

Key features of the study:

  • This report provides an in-depth analysis of the global intravenous solutions market, market size (US$ Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2025 - 2032, considering 2024 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global intravenous solutions market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global intravenous solutions market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global intravenous solutions market.

Detailed Segmentation:

  • Global Intravenous Solutions Market, By Solution type:
    • Saline
    • Normal Saline (0.9% NaCl)
    • Hypertonic Saline
    • Dextran
    • Lactated Ringer's
    • Amino Acid
    • Vitamins & Minerals
    • Heparin and Trace Elements
    • Mixed Solutions
  • Global Intravenous Solutions Market, By Bag type:
    • Large Volume Bags (greater than 250ml)
    • Small Volume Bags (less than 250ml)
  • Global Intravenous Solutions Market, By Application:
    • Basic IV Solution
    • Nutritional IV Solution
    • Blood IV Solution
    • Drug IV Solution
    • Irrigation IV Solution
  • Global Intravenous Solutions Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers
    • Home Care Settings
  • Global Intravenous Solutions Market, By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Baxter International Inc.
    • ICU Medical, Inc.
    • Braun Melsungen Ag
    • Grifols, S.A.
    • Fresenius Kabi USA, LLC
    • Vifor Pharma Management Ltd.
    • JW Life Science
    • Amanta Healthcare
    • Axa Parenterals Ltd.
    • Salius Pharma Private Limited.
    • Pfizer, Inc.
    • Otsuka Pharmaceutical Co., Ltd
    • Ajinomoto Co., Inc.
    • Braun Melsungen AG
    • Soxa Formulations & Research Pvt.Ltd
    • Sichuan Kelun Pharmaceutical Co Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Solution
    • Market Snapshot, By Bag Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology
  • Porter's Five Forces Analysis

4. Global Intravenous Solutions Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • COVID-19 Impact on the market

5. Global Intravenous Solutions Market, By Solution, 2020 - 2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Saline
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Normal Saline (0.9% NaCl)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Hypertonic Saline
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Dextran
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Lactated Ringer's
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Amino Acid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Vitamins & Minerals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Heparin and trace elements
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Mixed Solutions
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Intravenous Solutions Market, By Bag Type, 2020 - 2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Large Volume Bags (greater than 250ml)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Small Volume Bags (less than 250ml)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Intravenous Solutions Market, By Application, 2020 - 2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Basic IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Nutritional IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Blood IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Drug IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Irrigation IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Intravenous Solutions Market, By End User, 2020 - 2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Ambulatory Surgery Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Home care Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global Intravenous Solutions Market, By Region, 2020 - 2032, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Company Profile
    • Baxter International Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • ICU Medical, Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • B. Braun Melsungen Ag
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Grifols, S.A
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Fresenius Kabi USA, LLC
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Vifor Pharma Management Ltd.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • JW Life Science
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Amanta Healthcare
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Axa Parenterals Ltd
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Salius Pharma Private Limited.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Pfizer, Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Otsuka Pharmaceutical Co., Ltd
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Ajinomoto Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Soxa Formulations & Research Pvt. Ltd
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Sichuan Kelun Pharmaceutical Co Ltd
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies

11. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. Section

  • References
  • Research Methodology
  • About Us and Sales Contact